The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model

Peroxisome proliferator-activated receptor α/δ (PPAR α/δ), regulating glucolipid metabolism and immune inflammation, has been identified as an effective therapeutic target in non-alcoholic steatohepatitis (NASH). Dual PPAR α/δ agonist, such as GFT505 (also known as elafibranor), demonstrated potenti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Liu, Linfu, Liu, Chuang, Zhao, Manyu, Zhang, Qianru, Lu, Ying, Liu, Ping, Yang, Hua, Yang, Jinliang, Chen, Xiaoxin, Yao, Yuqin
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7743980/
https://ncbi.nlm.nih.gov/pubmed/33326461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0243911
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares